Delivery Order SPE2DB20D3103-SPE2DB25FQ2U5
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a $13,327.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its Pennsylvania facility. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $47,754.38. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for ultimate completion by July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill the order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,042.99 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and requires performance at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $11,735.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,144.14 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This firm fixed-price delivery order, awarded on August 20, 2025, with a completion date of August 21, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a $7,184.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a single pharmaceutical procurement under the company's broader federal medical supply framework supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $1,709.46. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...